Russell Kern

Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease

E. Snyder, R. Gonzalez, I. Garitaonandia, 2016, Scientific Reports.

Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease

L. Laurent, E. Snyder, A. Crain, 2016, Cell transplantation.

Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease.

L. Laurent, E. Snyder, A. Crain, 2016, Cell transplantation.

Novel Approach to Stem Cell Therapy in Parkinson's Disease.

A. Evans, R. Gonzalez, I. Garitaonandia, 2018, Stem cells and development.

Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease

L. Laurent, E. Snyder, A. Crain, 2016, Cell transplantation.

Supplementation of specific carbohydrates results in enhanced deposition of chondrogenic‐specific matrix during mesenchymal stem cell differentiation

R. Gonzalez, I. Garitaonandia, Andrey Semechkin, 2018, Journal of tissue engineering and regenerative medicine.

Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model

C. Borlongan, R. Gonzalez, I. Garitaonandia, 2019, Theranostics.